Dimethylamylamine (DMAA), also known as 1,3-dimethylamylamine or methylhexanamine, is a synthetic stimulant once marketed in “pre-workout” and “fat burner” supplements. It acts on the sympathetic nervous system, which is why users report sharp increases in alertness and drive. At the same time, this class of compounds can raise heart rate and blood pressure and has been linked to serious adverse events. Today, DMAA is prohibited in drug-tested sport and has been the subject of regulatory actions in several countries. If you are researching DMAA because of claims about weight loss or workout performance, this guide gives you a clear, evidence-based overview of what it is, how it has been used, its risks, who should avoid it, and safer alternatives.
Essential Insights for Dimethylamylamine Users
- Reported effects include short-term alertness and energy; evidence for fat loss or strength gains is limited.
- Safety concern: can acutely raise blood pressure and heart rate, especially with caffeine or heat stress.
- No established safe dosage for dietary use; historic labels listed ~25–75 mg per serving, which is not recommended.
- Avoid if you have cardiovascular disease, high blood pressure, are pregnant or breastfeeding, or compete in drug-tested sports.
Table of Contents
- What is dimethylamylamine?
- Does it work and for what?
- How to interpret labels, dosage and timing
- Common mistakes, risks and interactions
- Who should avoid DMAA?
- What the evidence and law say
What is dimethylamylamine?
Dimethylamylamine (DMAA) is a small aliphatic amine developed decades ago as a nasal decongestant. In the 2000s, it resurfaced in sports nutrition products marketed for energy, focus, and “thermogenic” effects. DMAA appears on labels under several names: 1,3-dimethylamylamine, 1,3-DMAA, methylhexanamine, 4-methylhexan-2-amine, and sometimes vague descriptors like “geranium extract.” Those euphemisms are important to recognize: despite marketing claims, modern evidence indicates DMAA is a synthetic compound; any natural occurrence in plants is either disputed or at trace levels insufficient for commercial extraction.
How it behaves in the body: DMAA is a sympathomimetic. That means it can stimulate adrenergic receptors or promote release of catecholamines (such as norepinephrine). Users typically feel a rapid onset of alertness, heightened drive, and appetite suppression—effects consistent with a stimulant. Because these pathways also constrict blood vessels and increase cardiac workload, the same mechanism that feels energizing can elevate blood pressure and heart rate.
Why it became controversial: DMAA moved quickly from niche ingredient to mainstream pre-workout component in the early 2010s. Reports of adverse events—including hypertension, palpitations, and heat-related illness during intense training—prompted scrutiny from health agencies. Athletic bodies classified DMAA as a prohibited stimulant; regulators challenged “natural” labeling and the legality of using DMAA in foods or supplements. Today, many countries treat DMAA as an unauthorized ingredient in dietary supplements, and significant penalties exist for its use in professional and collegiate sport.
What products still contain it? Legitimate brands have largely removed DMAA due to enforcement and liability. However, “grey market” formulas, online-only imports, or products with disguised ingredient names still appear. Some labels use near-synonyms (e.g., “geranium oil extract”) or list DMAA analogs. Consumers should be cautious: even if DMAA is not named plainly, combinations of multiple stimulants (DMAA plus caffeine, synephrine, yohimbine, or higenamine) can compound risk.
Takeaway: DMAA is a potent synthetic stimulant with a risk profile that extends beyond everyday caffeine. Understanding its names, pharmacology, and the reasons behind regulatory actions will help you identify it on labels and weigh the real-world tradeoffs.
Does it work and for what?
DMAA has been promoted for two main outcomes: (1) improved workout performance through heightened focus and perceived energy, and (2) accelerated fat loss via “thermogenesis.” What does the evidence say?
Performance claims: There are small, short-term studies on DMAA-containing pre-workouts—nearly all confounded by caffeine and other stimulants. Participants often report increased alertness and drive. Some protocols show modest upticks in training volume or perceived readiness, but these findings are difficult to attribute specifically to DMAA. The stronger and more consistent performance enhancer in most blends is caffeine, which alone improves endurance and high-intensity effort at 3–6 mg/kg. Without caffeine, DMAA-specific performance data are sparse and methodologically limited.
Body composition claims: Stimulants can transiently increase energy expenditure and suppress appetite. That does not guarantee meaningful fat loss in free-living conditions. Over weeks to months, calorie balance, protein intake, sleep, and progressive training dominate outcomes. DMAA may reduce appetite for a few hours and raise heart rate, yet evidence for clinically significant, sustained fat loss attributable to DMAA is weak. Moreover, any small calorie-burn advantage is offset by higher cardiovascular strain and regulatory concerns.
Focus and motivation: DMAA’s most reliable effect is subjective—people feel “switched on.” For some, that sharpened focus is attractive during pre-workout routines. However, the same sympathetic surge can tip into anxiety, jitteriness, or elevated blood pressure, particularly in warm environments or with insufficient hydration.
What about “stacking”? Many historical DMAA products combined multiple stimulants. Stacking ingredients can magnify arousal, but also compounds side effects. Caffeine plus DMAA, for instance, can produce higher peak blood pressures than either alone. Sensitive individuals or those with borderline hypertension may experience pronounced effects after a single serving.
Bottom line: DMAA can acutely increase alertness and arousal, but decisive, high-quality evidence for meaningful improvements in strength, power, or fat loss—above what caffeine already provides—is limited. Given the imbalance between modest potential benefits and documented safety and regulatory risks, the overall risk–reward profile is unfavorable for most people.
How to interpret labels, dosage and timing
There is no established safe or recommended “dietary” dose of DMAA. Regulatory authorities do not recognize DMAA as a lawful dietary ingredient in many jurisdictions, and athletic organizations classify it as prohibited. Nonetheless, understanding how labels have historically presented DMAA helps you identify and avoid it.
Reading the label:
- Ingredient names: Look for “1,3-dimethylamylamine,” “methylhexanamine,” “1,3-DMAA,” “4-methylhexan-2-amine,” or ambiguous terms like “geranium extract” or “geranium oil.”
- Proprietary blends: DMAA may be hidden inside blends without individual milligram amounts. Stimulants listed together (caffeine, synephrine, yohimbine, hordenine, higenamine) suggest a high-arousal product.
- Analogues and lookalikes: Closely related compounds may appear with different names. Treat any “new” amine stimulants with caution.
Historical dosing patterns (for awareness, not endorsement): Older products commonly listed ~25–75 mg of DMAA per serving, often with 100–300 mg caffeine. Some users took multiple scoops or dosed twice daily—behaviors linked to more side effects. Because DMAA pharmacokinetics can vary with co-ingested caffeine and individual sensitivity, “copying” someone else’s experience is risky.
Timing claims versus reality: Labels sometimes advise taking DMAA “30 minutes pre-workout.” In practice, peak stimulant effects may coincide with the most intense, heat-generating portion of exercise. That overlap raises heart rate and core temperature at the same time—conditions that can amplify risk during strenuous workouts, especially in hot weather or with inadequate fluids.
If you see DMAA on a label:
- Confirm the product is legal where you live (many countries ban DMAA in supplements).
- Consider sport eligibility: DMAA is prohibited in competition; a single use can trigger a positive test.
- Weigh alternatives: If you want energy, caffeine alone—in well-studied ranges like 100–200 mg—is both legal and predictable for most adults. For training adaptations, evidence-backed options include creatine monohydrate (3–5 g/day), beta-alanine (3.2–6.4 g/day, divided), and nitrate from foods like beetroot.
Practical stance on “dosage”: Because authorities have not established a safe intake and because adverse cardiovascular effects have been reported around historically labeled doses, the prudent dosage for consumers is zero. If you encounter DMAA on a label, the safer action is to choose a different product.
Common mistakes, risks and interactions
Even a single serving of a DMAA-containing product can cause noticeable cardiovascular stimulation. The most common mistakes increase that risk further:
Stacking stimulants: Combining DMAA with caffeine, synephrine (bitter orange), yohimbine, or high-dose pre-workout “blends” can raise blood pressure and heart rate more than any single stimulant alone. Because many products already include caffeine, adding coffee or energy drinks on top compounds exposure.
Training in heat or while dehydrated: DMAA’s vasoconstrictive actions may impair heat dissipation. Intense exercise, hot environments, and inadequate hydration create a “perfect storm” for dizziness, palpitations, and heat-related illness.
Multiple scoops and redosing: Stimulant “tolerance” leads some users to double-scoop or dose again later in the day. Redosing compresses recovery time for the cardiovascular system and can disrupt sleep, which in turn worsens blood pressure control and injury risk.
Drug interactions:
- Antidepressants (especially monoamine oxidase inhibitors) and some decongestants can interact with sympathomimetics, increasing the risk of hypertensive episodes.
- Thyroid medications may potentiate stimulant sensitivity.
- Antihypertensives can be blunted by catecholamine surges, undermining blood pressure control.
- Other performance drugs (e.g., clenbuterol-like beta-agonists) additively stress the heart.
Medical red flags: Individuals with a history of hypertension, arrhythmia, structural heart disease, stroke, glaucoma, hyperthyroidism, panic disorder, or kidney disease face higher risk. Because DMAA’s effects can be abrupt, first-time use may unmask an underlying condition.
Quality and contamination: Products bought from unverified sellers can be misbranded—containing more (or less) DMAA than the label states, substituted stimulants, or additional undisclosed ingredients. Without third-party certification, you cannot assume dose accuracy.
Legal and career consequences: DMAA is prohibited in competition. A positive test can lead to suspensions, lost scholarships, or contract penalties. Athletes have strict liability for what they ingest; “I did not know” rarely prevents sanctions.
What to do if you experience symptoms: Stop activity, hydrate, and seek medical care urgently if you develop chest pain, severe headache, fainting, or shortness of breath after using any stimulant product. Bring the label to your clinician if possible.
Who should avoid DMAA?
Because DMAA is a potent sympathomimetic with unresolved safety concerns, a conservative avoidance list protects many readers:
- Anyone with cardiovascular concerns: hypertension, coronary artery disease, arrhythmias, heart failure, prior stroke or TIA, peripheral vascular disease.
- Pregnant or breastfeeding individuals: Stimulant exposure is avoidable risk; DMAA is neither necessary nor recommended in these life stages.
- Teenagers and young adults: Developing cardiovascular and nervous systems are more vulnerable to stimulant-induced blood pressure spikes and sleep disruption.
- People with anxiety, panic disorder, or insomnia: Sympathetic activation can precipitate anxiety and disturb sleep architecture.
- Hyperthyroidism or glaucoma: Sympathomimetics can worsen symptoms via increased ocular pressure or metabolic rate.
- Kidney or liver disease: Reduced clearance raises exposure and side-effect likelihood.
- Those on interacting medications: Particularly MAO inhibitors, tricyclic antidepressants, some SNRIs, decongestants (e.g., pseudoephedrine), thyroid hormones, beta-agonists, and certain weight-loss drugs.
- Athletes in tested sports: DMAA remains prohibited in competition; a single use can produce an adverse analytical finding.
- Anyone with a family history of early cardiac events: Even mild hypertensive responses during exertion can be risky with underlying predispositions.
If you fall into any of these categories and you are tempted by “fat burner” claims, consider safer, legal alternatives with predictable effects: basic caffeine (if appropriate and well tolerated), creatine for strength and power, or diet-first strategies for fat loss (adequate protein and fiber, calorie awareness, sleep optimization). Discuss any supplement strategy with a qualified clinician, especially if you have medical conditions or take prescription drugs.
What the evidence and law say
Regulators and sports authorities have taken consistent positions on DMAA:
United States: The U.S. Food and Drug Administration (FDA) has issued determinations and enforcement actions indicating DMAA is not an approved dietary ingredient for use in supplements. In FDA communications, officials have raised safety concerns—particularly cardiovascular risks—and challenged products listing DMAA or disguising it as “geranium extract.” These actions reflect a broader principle: compounds with drug-like stimulant properties cannot be added to foods or supplements without evidence of lawful status and safety.
International: Health authorities in several countries have restricted DMAA in consumer products due to safety concerns, and national anti-doping organizations align with the World Anti-Doping Agency (WADA).
Sport: WADA classifies DMAA (methylhexanamine) as a prohibited stimulant in competition. Importantly, “herbal” or “extract” labeling provides no exemption. Athletes are strictly liable for substances in their bodies; supplements are a known risk vector.
Research snapshot: Recent laboratory and review literature describes DMAA as a sympathomimetic with adrenergic activity. In vitro work shows receptor-level actions consistent with vasoconstriction and pressor effects, aligning with real-world reports of elevated blood pressure. Human data are not robust by modern standards and are often confounded by caffeine, but the mechanistic signal and post-market safety experience have been sufficient for regulators and anti-doping bodies to act.
Practical takeaway: Even if DMAA offers a noticeable “kick,” the legal, cardiovascular, and career downsides are substantial. If your goal is performance, consider caffeine (with individualized dosing and timing), creatine monohydrate for strength and power, and evidence-based training and nutrition. If your goal is weight management, focus on sustainable calorie control, protein adequacy (e.g., 1.6–2.2 g/kg/day for active individuals), and sleep—interventions that move the needle without jeopardizing health or eligibility.
References
- 1,3-dimethylamylamine (1,3-DMAA) (10/3/2016) 2016 (Regulatory memo)
- The Prohibited List 2025 (Prohibited List)
- In Vitro Activation of Human Adrenergic Receptors and Pharmacokinetic Profiling of Stimulants Used in Sport Supplements 2024 (Laboratory Study)
- Adverse Effects of Nutraceuticals and Dietary Supplements 2023 (Review)
Disclaimer
This article is for general information and education. It is not medical advice and does not replace consultation with a qualified healthcare professional who can consider your individual health, medications, and goals. Do not start, stop, or change any supplement or medication based on this article without medical guidance. If you experience chest pain, severe headache, fainting, or shortness of breath after using any stimulant product, seek urgent medical care.
If you found this guide useful, please consider sharing it on Facebook, X (formerly Twitter), or your preferred platform, and follow us for future updates. Your support helps us continue creating clear, trustworthy health content.
